Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors
- PMID: 15115227
Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors
Abstract
Background: Transfusion of safe blood requires a safe donor. The voluntary donor movement encompasses the concept of a donor who is free from transfusion transmissible infections. It is now mandatory to screen blood for hepatitis B surface antigen, antibodies to HIV-1 and HIV-2, antibodies to hepatitis C virus, syphilis and malarial parasites.
Methods: Between 1996 and 2002, 235 461 donors were screened for markers of hepatitis B virus, and HIV-1 and HIV-2 using commercially available ELISA kits, VDRL test for syphilis and Geimsa stain for the malarial parasite, respectively. A total of 56 476 donors were screened for hepatitis C virus antibodies from June 2001 to December 2002, using third-generation ELISA kits.
Results: The proportion of voluntary donors increased from 47% to 56% during the study period. The prevalence of HIV showed a steady increase from 0.16% in 1996 to 0.3% in 2002. The prevalence of hepatitis B surface antigen decreased from 1.55% to 0.99%. VDRL reactivity did not show any trend and ranged between 0.11% and 0.66%. Hepatitis C virus antibodies showed a prevalence of 0.4%. The prevalence of all markers was significantly less in voluntary donors. Among the voluntary donors, transfusion transmissible disease markers were significantly less in student donors as compared to other donors.
Conclusion: A change-over to a voluntary donor service would considerably reduce the number of infectious donors and, among voluntary donors, student donors are the safest.
Similar articles
-
Infectious markers in blood donors of East Delhi: prevalence and trends.Indian J Pathol Microbiol. 2004 Oct;47(4):477-9. Indian J Pathol Microbiol. 2004. PMID: 16295370
-
Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.Jpn J Infect Dis. 2004 Apr;57(2):49-51. Jpn J Infect Dis. 2004. PMID: 15118208
-
Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.Transfusion. 2007 Jan;47(1):74-9. doi: 10.1111/j.1537-2995.2007.01066.x. Transfusion. 2007. PMID: 17207233
-
Hepatitis B virus blood screening: unfinished agendas.Vox Sang. 2006 Jul;91(1):1-12. doi: 10.1111/j.1423-0410.2006.00773.x. Vox Sang. 2006. PMID: 16756595 Review.
-
Transfusion-transmitted infectious diseases.Biologicals. 2009 Apr;37(2):71-7. doi: 10.1016/j.biologicals.2009.01.002. Epub 2009 Feb 20. Biologicals. 2009. PMID: 19231236 Review.
Cited by
-
Patient Blood Management and Its Role in Supporting Blood Supply.J Blood Med. 2023 Nov 30;14:595-611. doi: 10.2147/JBM.S387322. eCollection 2023. J Blood Med. 2023. PMID: 38053640 Free PMC article. Review.
-
Anti-HBc screening in Indian blood donors: still an unresolved issue.World J Gastroenterol. 2008 Sep 14;14(34):5327-30. doi: 10.3748/wjg.14.5327. World J Gastroenterol. 2008. PMID: 18785287 Free PMC article.
-
Risk factors for chronic hepatitis B virus infection among blood donors in Bangalore, India.Transfus Med. 2010 Dec;20(6):414-20. doi: 10.1111/j.1365-3148.2010.01032.x. Epub 2010 Aug 18. Transfus Med. 2010. PMID: 20726953 Free PMC article.
-
Current testing strategies for hepatitis C virus infection in blood donors and the way forward.World J Gastroenterol. 2014 Mar 21;20(11):2948-54. doi: 10.3748/wjg.v20.i11.2948. World J Gastroenterol. 2014. PMID: 24659885 Free PMC article. Review.
-
Prevalence and trends of hepatitis B virus, Hepatitis C virus, Human immunodeficiency virus 1, 2 and syphilis infections among blood donors in a regional transfusion center in Punjab, India: A 3 years study.Indian J Sex Transm Dis AIDS. 2020 Jan-Jun;41(1):22-29. doi: 10.4103/0253-7184.196887. Epub 2016 Dec 28. Indian J Sex Transm Dis AIDS. 2020. PMID: 33062977 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Medical